In less than two years, the US conglomerate has unveiled a spinoff, endured an Elliott siege and split itself. Now one of the companies is paying $15 bln to buy a chemicals peer. For all the churning cogs, there’s little value to show. Not all carve-up contraptions run smoothly.
